Human Biome S.A. Joins Global Innovators at The Microbiome Times Forum in Copenhagen

Representing the forefront of Central European biotechnology, a senior leadership delegation from Human Biome S.A. recently traveled to Denmark to attend The Microbiome Times Forum in Copenhagen.

A Strong Delegation for Global Collaboration

Widely recognized as one of the world’s premier conferences dedicated to the translation of microbiome science into scalable commercial therapeutics, the forum serves as a critical meeting ground for global biopharma executives, leading clinical researchers, and cutting-edge biotech innovators.

To maximize the collaborative and scientific potential of the event, Human Biome S.A. deployed a robust expert delegation. Our CEO, prof. Jarosław Biliński, MD, was joined by senior scientific and operational leaders from the company: Ewa Olchawa PhD, Agnieszka Romanik-Chruścielewska PhD, and Adrian Górecki PhD.

The team engaged in high-level knowledge exchange, roundtable discussions, and networking sessions with international experts, exploring the next generation of biotherapeutic platforms and regulatory pathways.

Shaping the Future of the Scientific Revolution

The forum highlighted a rapid acceleration in microbiome-based drug development, validating Human Biome’s strategic focus on integrating artificial intelligence, advanced culturomics, and biosynthetic biotherapeutics.

The insight and international connections secured during the Copenhagen summit will directly feed back into our ongoing research and development pipeline. The Human Biome S.A. team returns to the laboratory and headquarters highly inspired, equipped with fresh perspectives to accelerate our mission of bringing life-changing microbiome therapies to market.

March, 2026